|
Volumn 274, Issue 7348, 2005, Pages 561-564
|
Remedying calcium and phosphate problems in chronic kidney disease
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADCAL;
ALFACALCIDOL;
ALUMINUM HYDROXIDE;
ALUMINUM SALT;
CALCICHEW;
CALCIMIMETIC AGENT;
CALCIUM;
CALCIUM ACETATE;
CALCIUM CARBONATE;
CALCIUM SALT;
CINACALCET;
GLUCONATE CALCIUM;
IRON;
LANTHANUM CARBONATE;
MAGNESIUM SALT;
PARATHYROID HORMONE;
PHOSEX;
PHOSPHATE;
PHOSPHATE BINDING AGENT;
SEVELAMER;
VITAMIN D;
ADJUVANT THERAPY;
ARTICLE;
BONE DISEASE;
BRAIN TOXICITY;
CALCINOSIS;
CALCIUM BLOOD LEVEL;
CALCIUM HOMEOSTASIS;
CHRONIC KIDNEY DISEASE;
CLINICAL TRIAL;
CONFUSION;
CONSTIPATION;
COST BENEFIT ANALYSIS;
DIET RESTRICTION;
DISEASE SEVERITY;
DRUG CHOICE;
DRUG COST;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG TOLERABILITY;
GASTROINTESTINAL SYMPTOM;
HEMODIALYSIS;
HORMONE ACTION;
HUMAN;
HYPERCALCEMIA;
HYPERMAGNESEMIA;
HYPERPHOSPHATEMIA;
HYPOCALCEMIA;
IRON DEFICIENCY;
KIDNEY FAILURE;
MAXIMUM PERMISSIBLE DOSE;
MUSCLE WEAKNESS;
NAUSEA;
PARATHYROID HORMONE RELEASE;
PATIENT COMPLIANCE;
PHOSPHATE BLOOD LEVEL;
PRURITUS;
RENAL OSTEODYSTROPHY;
RISK BENEFIT ANALYSIS;
SECONDARY HYPERPARATHYROIDISM;
SIDE EFFECT;
SKIN CALCIFICATION;
SKIN INFLAMMATION;
SKIN NECROSIS;
SOFT TISSUE CALCIFICATION;
THIRST;
|
EID: 19044390360
PISSN: 00316873
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (5)
|
References (0)
|